On March 28, 2023 BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, reported that the Company will be presenting three posters at two upcoming scientific conferences: ESMO (Free ESMO Whitepaper)’s European Lung Cancer Congress (ELCC) 2023 and the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2023 (Press release, BerGenBio, MAR 28, 2023, View Source [SID1234629649]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
European Lung Cancer Conference 2023
March 29 – April 1, 2023
Bella Center – Copenhagen, Denmark
Poster Title: Phase 1b/2a safety and tolerability study of bemcentinib with pembrolizumab/carboplatin/pemetrexed in subjects with untreated advanced or metastatic non-squamous NSCLC with/without STK11 mutations
Session Title: Poster Display session (ID 51)
Session Date & Time: Friday March 31, 2023, 12:00 PM – 12:45 PM
Location: Exhibition and Poster area
Presentation Number: 78TiP
American Association for Cancer Research Annual Meeting 2023
April 14 – 19, 2023
Orlando County Convention Center – Orlando, Florida
Poster Title: AXL as a Therapeutic Target in STK11 mutant NSCLC
Session Title: Combination Immunotherapies 1
Session Date and Time: Monday Apr 17, 2023, 1:30 PM – 5:00 PM
Location: Section 39
Poster Board Number: 18
Abstract Presentation Number: 3245
Poster Title: Combined inhibition of AXL and ATR enhances replication stress, cell death and immune response in small cell lung cancer
Session Title: DNA Repair / Molecular Classification of Tumors for Diagnostics, Prognostics, and Therapeutic Outcomes
Session Date and Time: Wednesday Apr 19, 2023, 9:00 AM – 12:30 PM
Location: Section 18
Poster Board Number: 8
Abstract Presentation Number: 6206
The posters from both conferences will be available on the Company’s website in the Scientific Presentations portion of the Investors section following their presentations.